Next-generation sequencing (NGS) is a group of technologies used to determine the order of DNA or RNA building blocks in biological samples. Unlike traditional sequencing methods that generally examine one DNA fragment at a time, many NGS systems analyze millions of fragments in parallel. This approach allows researchers and laboratories to study genetic information across large sections of a genome.
NGS developed from earlier DNA sequencing methods as advances in chemistry, imaging, computing, and molecular biology made large-scale sequencing increasingly practical. It is now used in genomic research, infectious disease studies, cancer research, agricultural science, and the investigation of inherited genetic conditions. The technology can examine targeted genes, groups of genes, entire genomes, or RNA-derived sequences, depending on the application.
Next-generation sequencing platforms combine specialized instruments, sequencing reagents, sample preparation materials, software, and data analysis workflows. These components work together to convert biological samples into digital sequence data that researchers can interpret.
How next-generation sequencing works
Although individual platforms use different methods, most NGS workflows follow a series of general steps.
Sample collection: DNA or RNA is obtained from a biological source, such as blood, tissue, microorganisms, plants, or cultured cells.
Sample preparation: Genetic material is extracted, measured, and assessed for quality.
Library preparation: DNA fragments are processed and fitted with short adapter sequences that allow them to interact with the sequencing platform.
Sequencing: The instrument detects signals associated with nucleotide identification as fragments are read.
Data processing: Specialized software converts instrument signals into sequence reads and evaluates their quality.
Bioinformatics analysis: The resulting data is compared with reference sequences or analyzed to identify genetic variations, gene expression patterns, or other biological features.
The accuracy and usefulness of the results depend on sample quality, the sequencing method, experimental design, and data interpretation. Different applications require different levels of sequence coverage and analytical detail.
Main types of NGS technologies
Several sequencing technologies are used in current research and clinical laboratory environments.
Short-read sequencing produces relatively short DNA sequence reads. It is widely used for whole-genome sequencing, targeted gene panels, RNA sequencing, and many other applications because large numbers of reads can be generated in a single run.
Long-read sequencing produces substantially longer reads, which can help researchers examine repetitive DNA regions, structural variations, and complex genomic arrangements that may be difficult to resolve using short reads alone.
Sequencing by synthesis identifies nucleotides through signals generated as complementary DNA strands are constructed. Different platforms use different chemistries and detection systems.
Semiconductor sequencing detects changes associated with hydrogen ions released during nucleotide incorporation rather than relying on optical imaging.
Single-molecule sequencing examines individual DNA molecules directly, enabling long reads and, with certain technologies, the observation of specific molecular features.
Each approach has distinct characteristics related to read length, throughput, accuracy, equipment requirements, and data analysis. The appropriate technology depends on the scientific question rather than on one universal performance measure.
Importance
Next-generation sequencing has changed how researchers investigate genetic information by making it possible to examine large numbers of DNA or RNA sequences in a single experiment. It supports research that would be difficult to conduct using methods limited to a small number of genetic regions. The technology also contributes to understanding how genetic differences relate to biological processes, disease mechanisms, and the characteristics of living organisms.
Genomic research and medical applications
NGS is used in several areas of healthcare and biomedical research. In cancer research, sequencing can help identify genetic alterations within tumor samples and support investigations into how tumors develop or respond to particular treatments. Inherited disease research uses sequencing to investigate genetic variants that may be associated with certain conditions.
Clinical use requires appropriate validation, quality controls, and interpretation by qualified professionals. A detected genetic variant does not automatically establish a diagnosis, and some results may remain uncertain because scientific knowledge is incomplete.
Infectious disease and public health research
Researchers use genomic sequencing to study bacteria, viruses, fungi, and other microorganisms. Comparing genetic sequences can help characterize pathogens, examine how they change over time, and investigate relationships between samples.
Public health laboratories may use sequencing as part of disease surveillance and outbreak investigations. The usefulness of these findings depends on representative sampling, reliable laboratory procedures, suitable reference data, and appropriate interpretation.
Agricultural and environmental applications
NGS is also relevant outside human healthcare. Agricultural researchers use it to study plant genomes, crop diversity, breeding characteristics, and potential resistance to environmental stresses. Environmental scientists can analyze genetic material from soil, water, and other samples to investigate microbial communities and biodiversity.
These applications demonstrate that sequencing is a general research technology rather than a method limited to medical testing.
Factors that influence sequencing results
Several technical factors affect the quality and usefulness of NGS data:
Sample quality: Degraded or contaminated material can affect library preparation and sequencing outcomes.
Read depth: The number of times a genomic region is read influences the ability to detect some variants.
Read length: Longer reads can help resolve repetitive regions and complex structural changes.
Sequencing errors: Each technology has characteristic error patterns that must be considered during analysis.
Bioinformatics: Data-processing methods and reference databases influence how sequence differences are identified.
Quality assurance: Laboratory controls and validated workflows help identify technical problems.
Sequencing results should therefore be evaluated in the context of the intended application, rather than by instrument specifications alone.
Recent Updates
Developments across the NGS field have focused on improving sequencing accuracy, expanding read lengths, increasing laboratory automation, and making genomic data analysis more efficient. Advances in computing and machine learning have also influenced how researchers process and interpret large sequencing datasets.
Emerging sequencing technologies and platforms
Short-read sequencing continues to support many large-scale genomic studies, while long-read technologies are increasingly used for applications involving complex genomes, structural variations, and difficult-to-sequence regions. Some newer methods also support the analysis of DNA modifications and other molecular characteristics.
Multi-omics research is another developing area. It combines genomic sequencing with other types of biological measurements, such as gene expression, proteins, or metabolites. These combined datasets can help researchers investigate biological processes from different perspectives, although integrating them requires additional analytical expertise.
Automation and NGS manufacturing processes
Manufacturing and laboratory workflows increasingly incorporate automated liquid handling, robotic sample preparation, digital tracking, and software-based quality monitoring. These technologies can help standardize repetitive procedures and manage larger sample volumes.
NGS manufacturing involves several interconnected activities, including instrument engineering, microfluidic component production where applicable, reagent formulation, flow-cell or consumable production, optical or electronic detection systems, and software development. Different manufacturers use different architectures, so the exact production process varies by platform.
Quality control is essential throughout manufacturing. Instrument calibration, reagent consistency, component testing, and verification of sequencing performance help ensure that equipment operates according to its intended specifications.
Data analysis and genomic privacy
The volume of sequencing data has increased the importance of secure data storage, efficient computing, and reproducible analysis workflows. Laboratories may use local computing infrastructure, cloud-based environments, or a combination of both.
Genomic information can also contain sensitive personal information. Organizations are paying greater attention to data access controls, secure transfer, retention policies, and the management of research consent. Technical improvements do not remove the need for appropriate governance and responsible handling of biological data.
Laws or Policies
Next-generation sequencing is affected by regulations and standards related to medical devices, laboratory quality, biological materials, research ethics, data protection, and clinical testing. Requirements depend on whether sequencing is used for research, routine clinical testing, pharmaceutical development, or public health monitoring.
Regulatory considerations in India
In India, the regulatory framework depends on the intended use of the sequencing platform and the associated diagnostic test. The Central Drugs Standard Control Organisation (CDSCO) oversees medical devices under the applicable provisions of the Drugs and Cosmetics Act and the Medical Devices Rules, 2017. Certain instruments, reagents, and in vitro diagnostic products may fall within these requirements.
Clinical laboratories must consider applicable quality requirements, professional standards, and laboratory accreditation criteria. The National Accreditation Board for Testing and Calibration Laboratories (NABL) provides accreditation frameworks relevant to medical testing laboratories, including requirements based on ISO 15189 where applicable.
Research involving human biological samples may also require ethics committee review, appropriate consent, and safeguards for participant information. The Digital Personal Data Protection Act, 2023, and applicable rules may be relevant when sequencing workflows process personal digital data, subject to their scope and implementation.
International quality and safety standards
International standards can help laboratories and manufacturers establish consistent processes. Examples include:
ISO 15189: Requirements for quality and competence in medical laboratories.
ISO 13485: Quality management requirements for medical device manufacturing.
ISO 14971: A framework for managing medical device risks.
Good laboratory practice principles: Practices supporting the quality and reliability of nonclinical laboratory studies where applicable.
These frameworks have different purposes and legal implications. Their relevance depends on the product, the laboratory's activities, and the jurisdiction in which the technology is used.
Tools and Resources
NGS workflows require specialized laboratory equipment, sequencing software, reference databases, and quality assessment tools. The tools selected depend on the sequencing platform, sample type, and research objective.
Sequencing platforms and manufacturers
Several companies develop sequencing instruments, reagents, and related technologies. Examples include:
Illumina: Known for short-read sequencing platforms used in genomic research and other applications.
Thermo Fisher Scientific: Develops sequencing technologies and semiconductor-based sequencing systems.
Oxford Nanopore Technologies: Develops nanopore sequencing platforms that can produce long reads.
Pacific Biosciences: Develops single-molecule sequencing systems, including long-read technologies.
Roche: Has a history of involvement in sequencing technologies and genomics research.
Product availability, platform specifications, and the scope of each company's current portfolio can change. These examples represent different approaches to sequencing rather than a ranking of manufacturers.
Bioinformatics and data analysis resources
NGS analysis commonly uses tools for quality control, sequence alignment, variant detection, and biological interpretation. Examples include FastQC for read-quality assessment, the Burrows–Wheeler Aligner for certain alignment workflows, and the Genome Analysis Toolkit for genomic analysis tasks.
Reference resources such as the National Center for Biotechnology Information (NCBI) databases help researchers access genomic sequences and related scientific information. The suitability of any tool depends on the organism, sequencing technology, data format, and analytical objective.
FAQs
What is next-generation sequencing used for?
NGS is used for genomic research, inherited disease investigations, cancer research, infectious disease surveillance, agricultural genetics, and studies of biological diversity.
What is the difference between short-read and long-read sequencing?
Short-read sequencing generates many relatively short DNA reads, while long-read sequencing produces longer sequences that can help resolve repetitive regions and complex structural variations.
How do NGS platforms differ?
NGS platforms differ in sequencing chemistry, detection methods, read length, throughput, accuracy, sample preparation, and data analysis requirements. Platform selection depends on the intended application.
What is involved in NGS manufacturing?
NGS manufacturing can involve instrument design, electronic or optical components, flow cells or other consumables, reagent production, software development, and quality control. The exact process varies by technology.
How is NGS data analyzed?
Bioinformatics software processes sequencing reads, evaluates their quality, compares them with reference sequences where appropriate, and identifies features relevant to the research question.
Conclusion
Next-generation sequencing enables large-scale analysis of DNA and RNA through technologies that examine many sequences in parallel. Short-read systems, long-read platforms, automated laboratory equipment, and bioinformatics tools support applications across medicine, public health, agriculture, and scientific research. Reliable results depend on sample quality, appropriate technology selection, rigorous quality controls, and careful data interpretation. Regulatory requirements and data protection practices remain important throughout sequencing research, manufacturing, and clinical use.